AI Index / Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc. (RXRX)
Recursion is integrating AI in drug discovery through automated synthesis platforms and active learning for precision chemistry and biology. The company relies on technology-enabled drug discovery processes to enhance efficiency in identifying novel drugs. The company is leveraging technology for precision chemistry and biology, aiming to reduce the time and cost of drug development. Recursion has several partnerships, including with NVIDIA and Exscientia to enhance capabilities in generative AI for molecular design.
Loading...
One is with Nvidia. Need I say more? The need for compute to do everything that we do, whether it's in biology, chemistry, it's complex problems, lots of data. I think there is so much value in terms of what can be done with the work that Exscientia is doing in generative AI, 2D, 3D design, quantum mechanics and so forth.
- Najat Khan
Similar Companies in the Swift AI Index
Quotes from recursion-pharmaceuticals Executives About Artificial Intelligence and Generative AI
This closed loop design, make test learn platform that's literally sat behind us is so it's designing molecules in the cloud... using active learning and automated synthesis.
- Dave Hallett
...the Tempus partnership that we've done already in the last six months...using causal AI and many other algorithms that we've developed.
- Najat Khan
...in terms of generative AI, especially let's talk about it in the molecular design space...
- Najat Khan
...we're a learning organization saying that Recursion is. And so every program that we execute on, every piece of data that we bring in house allows our operating system to actually learn and to get better.
- Dave Hallett